Medifast, Inc. (MED)
| Previous close | 69.74 |
| Open | 69.00 |
| Bid | 68.97 x 1200 |
| Ask | 69.33 x 800 |
| Day's range | 68.27 - 69.38 |
| 52-week range | 61.94 - 131.42 |
| Volume | |
| Avg. volume | 172,639 |
| Market cap | 752.951M |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | 6.30 |
| EPS (TTM) | 10.98 |
| Earnings date | 19 Feb 2024 - 23 Feb 2024 |
| Forward dividend & yield | 6.60 (9.46%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | 73.00 |
Insider Monkey12 Very High Yield Dividend Stocks With Upside Potential
In this article, we discuss 12 very high yield dividend stocks with upside potential. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Very High Yield Dividend Stocks With Upside Potential. Many investors are drawn to dividend investing for various reasons, but among […]
ZacksMedifast (MED) Poised on OPTAVIA ACTIVE Line Amid Cost Woes
Medifast (MED) is proactively positioning itself to tap into the increasing demand for weight loss medications, showcasing a commitment to staying in touch with market trends.
Insider MonkeyBillionaire Jim Simons’ Top 12 High-Dividend Stocks
In this article, we discuss billionaire Jim Simons’ top 12 high-dividend stocks. You can skip our detailed analysis of Renaissance Technologies’ holdings and past performance, and go directly to read Billionaire Jim Simons’ Top 5 High-Dividend Stocks. Renaissance Technologies, founded by Jim Simons, is a legendary hedge fund known for its innovative quantitative strategies and […]
